Balyasny Asset Management
ONCE

Balyasny Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Balyasny Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100,000
Closed -$10.5M – 1777
2019
Q2 		$10.5M Buy
+100,000
New +$10.8M 0.07% 394

Balyasny Asset Management's ONCE Position: Q4 2019 in Review

Balyasny Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 86,106 shares — an estimated $8.35M sold.

Balyasny Asset Management first reported a position in ONCE in Q2 2016 and held it in 13 quarters. The position peaked at $11.8M in Q3 2016. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Balyasny Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Balyasny Asset Management sold 86,106 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $8.35M.
  • Balyasny Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2016 and held it in 13 quarters.
  • Balyasny Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $11.8M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Balyasny Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.